Cva Family Office, LLC Charles River Laboratories International, Inc. Transaction History
Cva Family Office, LLC
- $634 Million
- Q1 2025
A detailed history of Cva Family Office, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 111 shares of CRL stock, worth $17,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111
Previous 41
170.73%
Holding current value
$17,440
Previous $7,000
128.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$959 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$799 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$673 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$376 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$306 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.99B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...